TBPH
Theravance Biopharma IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$843.92M
P/E Ratio
7.34
EPS
$2.23
Beta
0.19
52W High
$21.03
52W Low
$9.10
50-Day MA
$16.07
200-Day MA
$16.35
Dividend Yield
—
Profit Margin
104.30%
Forward P/E
7.65
PEG Ratio
-0.05
About Theravance Biopharma Inc
Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe, and Asia. The company is headquartered in George Town, the Cayman Islands.
Fundamentals
| Revenue (TTM) | $109.78M |
| Gross Profit (TTM) | $77.98M |
| EBITDA | $6.58M |
| Operating Margin | -33.10% |
| Return on Equity | 50.20% |
| Return on Assets | 0.76% |
| Revenue/Share (TTM) | $2.17 |
| Book Value | $5.64 |
| Price-to-Book | 2.90 |
| Price-to-Sales (TTM) | 7.69 |
| EV/Revenue | 4.462 |
| EV/EBITDA | 3.46 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 15.00% |
| Shares Outstanding | $51.55M |
| Float | $24.04M |
| % Insiders | 4.74% |
| % Institutions | 99.12% |
Historical Volatility
HV 10-Day
22.19%
HV 20-Day
19.12%
HV 30-Day
20.71%
HV 60-Day
68.41%
HV Rank
0.8%
Volatility is currently expanding
Analyst Ratings
Consensus ($17.20 target)
3
Buy3
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026